U
UPMC
UPMC is a Series A to Series B stage investment firm. It has made 10 investments. 59% of their portfolio is in Healthcare. Average disclosed round size is $19.7M (across 17 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
FY
Fiona Yung
Sr. Director, Investments
MK
Matthias Kleinz
Life Science Investor and Executive Vice President
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| OOptain Health | Series A | $26M | Sep 2025 |
| Ipo | $50M | Jan 2025 | |
| Ipo | $50M | Jan 2025 | |
| Series B | $21.8M | Nov 2021 | |
| Series B | $24M | Sep 2021 | |
| Series B | $24M | Sep 2021 | |
| GGlobin Solutions | Unknown | $1.8M | Mar 2020 |
| Series A | $11M | Mar 2019 | |
| Series A | $11M | Mar 2019 | |
| Series A | $11M | Jan 2019 | |
| GGlobin Solutions | Series A | $5M | May 2018 |
| Unknown | $8.5M | Jan 2017 | |
| KKoda Health | Series A | $7M | — |
| AAvista Therapeutics | Seed | $10M | — |
| MMedCPU | Unknown | $35M | — |
| Unknown | $3M | — | |
| Series C | $36M | — |
Top Co-Investors
Providence Ventures7 shared
Threshold Ventures6 shared
McKesson Ventures6 shared
UPMC Enterprises5 shared
Philips Ventures5 shared
Memorial Hermann4 shared
Novartis Venture Fund4 shared
MemorialCare Innovation Fund4 shared
Cleveland Clinic4 shared
Cone Health3 shared
Northwell Health1 shared
Memorial Hermann Health System1 shared
Insight Partners1 shared
Techstars1 shared
Merck1 shared
Labcorp1 shared
Ascension Ventures1 shared
Heritage Group1 shared
Novartis Pharma AG1 shared
Last updated: 20 October 2026